Rituximab for auto-immune alveolar proteinosis, a real life cohort study

BACKGROUND: Whole lung lavage is the current standard therapy for pulmonary alveolar proteinosis (PAP) that is characterized by the alveolar accumulation of surfactant. Rituximab showed promising results in auto-immune PAP (aPAP) related to anti-GM-CSF antibody. METHODS: We aimed to assess efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Soyez, Berenice, Borie, Raphael, Menard, Cedric, Cadranel, Jacques, Chavez, Leonidas, Cottin, Vincent, Gomez, Emmanuel, Marchand-Adam, Sylvain, Leroy, Sylvie, Naccache, Jean-Marc, Nunes, Hilario, Reynaud-Gaubert, Martine, Savale, Laurent, Tazi, Abdellatif, Wemeau-Stervinou, Lidwine, Debray, Marie-Pierre, Crestani, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918901/
https://www.ncbi.nlm.nih.gov/pubmed/29695229
http://dx.doi.org/10.1186/s12931-018-0780-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918901/
https://www.ncbi.nlm.nih.gov/pubmed/29695229
http://dx.doi.org/10.1186/s12931-018-0780-5

Ejemplares similares